Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)

v2.4.0.8
Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Condensed Consolidated Statements Of Operations And Comprehensive Loss        
Revenue $ 14,785    $ 14,785   
Expenses        
General and administrative 129,318 67,961 249,986 242,660
Professional fees 119,510 153,226 412,532 310,585
Salaries and office administrative fees 457,355 179,846 670,518 569,238
Research and development 1,071,984 524,534 2,733,742 1,758,372
Total Operating Expenses 1,778,167 925,567 4,066,778 2,880,855
Net Operating Loss (1,763,382) (925,567) (4,051,993) (2,880,855)
Other Income        
Grants received       143,987   
Loss on derivative remeasurement (4,130,562)    (3,363,561)  
Net Other Expenses (4,130,562)    (3,219,574)   
Provision for income taxes            
Net Loss (5,893,944) (925,567) (7,271,567) (2,880,855)
Other Comprehensive Loss        
Foreign currency translation adjustments (19,893) (6,478) (33,731) (18,336)
Total Other Comprehensive Loss (19,893) (6,478) (33,731) (18,336)
Net Comprehensive Loss $ (5,913,837) $ (932,045) $ (7,305,298) $ (2,899,191)
Net Loss per Share - Basic and Diluted $ (0.44) $ (0.08) $ (0.56) $ (0.27)
Weighted Average Shares Outstanding - Basic and Diluted 13,524,998 11,086,237 13,057,866 10,649,152